Broadstreet is pleased to have contributed to seven studies being presented at ISPOR on subjects ranging from patient preferences for chronic obstructive pulmonary disease (COPD) maintenance treatment delivery devices to…

Phenylketonuria (PKU) is a rare genetic disorder that causes harmful levels of the dietary protein phenylalanine (Phe), an essential amino acid and a fundamental building block of protein, to build…

Qualitative research can is valuable for its potential to provide in depth insights into complex issues and is particularly valuable for capturing patient perspectives. It can be used to inform…

Broadstreet will be featuring seven of our research projects at ISPOR Europe 2025. Subjects range from health-related quality-of-life in hypophosphatasia to physician perspectives on unmet need and treatment options in…

Broadstreet takes of a broad variety of work in the health economics and outcomes space. We thought we would share a few of our recent publications which reflect that diversity.…

ISPOR is coming to Canada this year, taking place in Montreal, May 5th to 8th. Broadstreet is pleased to be involved in six studies being presented on subjects ranging from…

Broadstreet is very pleased to be welcoming an old friend and new vice president to the team, Suzanne McMullen. She has known Shelagh and Karissa since the early days of…

ISPOR Europe is returning to Barcelona this year and Broadstreet is pleased to be there with six studies to present on subjects ranging from patient preferences for early oncology trial…

A few weeks ago, the National Institute for Health and Care Excellence (NICE) released a position statement on the use of Artificial Intelligence (AI) in evidence generation. Their announcement came…